Table 3.
Blood Parameters | MAFLD | Control | t | p Value |
---|---|---|---|---|
WBC, ×109/L | 6.30 ± 1.63 | 5.82 ± 1.57 | 13.0958 | <0.001 |
RBC, ×1012/L | 4.86 ± 0.47 | 4.72 ± 0.46 | 13.1568 | <0.001 |
HGB, g/L | 142.54 ± 15.93 | 138.17 ± 16.72 | 11.5679 | <0.001 |
PLT, ×109/L | 247.11 ± 63.43 | 238.42 ± 63.68 | 5.9598 | <0.001 |
NEUT%, % | 58.26 ± 8.09 | 58.49 ± 8.59 | −1.1907 | 0.234 |
LYMPH%, % | 33.88 ± 7.59 | 33.56 ± 7.99 | 1.8054 | 0.071 |
MONO%, % | 5.43 ± 1.32 | 5.56 ± 1.44 | −4.2614 | <0.001 |
EO%, % | 2.01 ± 1.70 | 1.97 ± 1.93 | 1.0541 | 0.292 |
BASO%, % | 0.42 ± 0.30 | 0.42 ± 0.33 | −0.0335 | 0.973 |
ALT, U/L | 24.90 ± 17.89 | 20.38 ± 20.96 | 9.8647 | <0.001 |
AST, U/L | 23.38 ± 8.55 | 22.97 ± 11.85 | 1.6300 | 0.103 |
ALP, U/L | 87.37 ± 24.71 | 86.01 ± 26.01 | 2.3148 | 0.021 |
TBIL, μmol/L | 16.64 ± 7.33 | 16.35 ± 7.58 | 1.7072 | 0.088 |
Urea, mmol/L | 5.10 ± 1.38 | 5.03 ± 1.45 | 2.3892 | 0.017 |
CR, μmol/L | 62.73 ± 13.60 | 61.71 ± 14.13 | 3.1972 | 0.001 |
TG, mmol/L | 2.10 ± 1.58 | 1.46 ± 1.08 | 22.3593 | <0.001 |
TC, mmol/L | 5.38 ± 1.05 | 5.17 ± 1.03 | 8.9123 | <0.001 |
HDL-C, mmol/L | 1.17 ± 0.27 | 1.33 ± 0.31 | −23.7332 | <0.001 |
LDL-C, mmol/L | 3.09 ± 0.85 | 2.93 ± 0.85 | 8.5616 | <0.001 |
SUA, μmol/L | 314.05 ± 86.62 | 277.21 ± 76.86 | 20.0556 | <0.001 |
FPG, mmol/L | 6.12 ± 1.82 | 5.63 ± 1.42 | 13.5223 | <0.001 |
HBA1c, % | 5.96 ± 1.10 | 5.64 ± 0.89 | 14.6705 | <0.001 |
MAFLD: Metabolic associated fatty liver disease; WBC: white blood cell; RBC: red blood cell; HGB: hemoglobin; PLT: platelets; NEUT%: percentage of neutrophils; LYMPH%: percentage of lymphocytes; MONO%: percentage of monocytes; EO%: percentage of eosinophils; BASO%: percentage of basophils; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; TBIL: total bilirubin; CR: creatinine; TG: triglyceride; TC: serum total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; SUA: serum uric acid; FPG: fasting plasma glucose; HBA1c: hemoglobin A1c.